Generated by GPT-5-mini| 10-Meter Walk Test | |
|---|---|
| Name | 10-Meter Walk Test |
| Acronym | 10MWT |
| Purpose | Assessment of walking speed |
| Field | Physical therapy |
| Developed | 1990s |
10-Meter Walk Test The 10-Meter Walk Test evaluates comfortable and fast walking speed over a short distance, used in rehabilitation, neurology, and gerontology. It is administered in clinics and research settings associated with institutions such as Mayo Clinic, Cleveland Clinic, Johns Hopkins Hospital, Massachusetts General Hospital, and Stanford Health Care. Prominent users include practitioners from World Health Organization, American Physical Therapy Association, National Institutes of Health, Centers for Disease Control and Prevention, and European Stroke Organisation.
The test quantifies gait performance by timing a subject over a measured distance, providing an objective metric comparable across cohorts studied at Harvard Medical School, University of Oxford, University of Cambridge, University of Toronto, and University College London. It is frequently reported alongside outcome measures used in trials funded by agencies like Wellcome Trust, Bill & Melinda Gates Foundation, National Science Foundation, Canadian Institutes of Health Research, and Australian National Health and Medical Research Council. Clinical investigators at Johns Hopkins Bloomberg School of Public Health, Karolinska Institutet, Tokyo University Hospital, Charité – Universitätsmedizin Berlin, and University of Sydney have contributed to the evidence base.
Standard administration uses a straight 14-meter corridor marked for acceleration, timed zone, and deceleration, often adapted in facilities such as Mayo Clinic School of Medicine, UCLA Medical Center, University of Pennsylvania Health System, Mount Sinai Hospital (New York), and Imperial College Healthcare NHS Trust. Protocol descriptions are cited in guidelines from American Heart Association, Royal College of Physicians, Scottish Intercollegiate Guidelines Network, European Respiratory Society, and International Society of Physical and Rehabilitation Medicine. Trained clinicians from Boston Children's Hospital, Texas Health Resources, Christchurch Hospital, Vanderbilt University Medical Center, and Karolinska University Hospital administer trials with standardized instructions, assistive device documentation, and timing procedures.
Results are expressed as meters per second and interpreted relative to thresholds used in stroke, spinal cord injury, and geriatric research at Rush University Medical Center, Cedars-Sinai Medical Center, Sunnybrook Health Sciences Centre, Bellevue Hospital, and Groote Schuur Hospital. Cutoffs inform prognoses and fall risk assessments cited in literature from University of Copenhagen, McGill University, Seoul National University Hospital, King's College London, and University of Melbourne. Comparative metrics are reported alongside measures like Berg Balance Scale results used at Mayo Clinic, Johns Hopkins, and National Rehabilitation Hospital datasets.
Modifications include different walkway lengths, dual-task conditions, and instrumentation with wearable sensors developed by teams at MIT, Caltech, ETH Zurich, University of Illinois Urbana-Champaign, and Georgia Institute of Technology. Laboratory enhancements employ motion capture from National Institutes of Health Clinical Center collaborations with Vicon, force plate integration popularized at Penn State University, and inertial measurement units researched at University of Glasgow, Trinity College Dublin, and Duke University Hospital.
Used across populations treated at Royal Melbourne Hospital, Addenbrooke's Hospital, Aarhus University Hospital, Hospital Clínic de Barcelona, and Auckland City Hospital, the test informs interventions for stroke rehabilitation, Parkinsonism, multiple sclerosis, and orthopaedic recovery. Trials led by teams at Columbia University Irving Medical Center, Yale New Haven Hospital, University of Michigan Health, Northwestern Memorial Hospital, and University of Zurich report its utility in tracking response to pharmacologic and surgical treatments, gait training, and community mobility programs funded by entities such as European Commission, Horizon 2020, and National Institute for Health Research.
Reliability and validity data derive from multicenter studies coordinated by academic centers including University of Nottingham, University of Birmingham, McMaster University, Queen Mary University of London, and University of Auckland. Psychometric properties are discussed in systematic reviews produced by teams at Cochrane Collaboration, Trinity College Dublin, King's College London, University of Newcastle (Australia), and University of Glasgow. Inter-rater, intra-rater, and test–retest reliability have been established across clinical settings in publications associated with Lancet Neurology, BMJ, JAMA, Neurology (journal), and Archives of Physical Medicine and Rehabilitation.
Limitations noted by investigators at University of Bern, University of Helsinki, University of São Paulo, Peking University Health Science Center, and University of Cape Town include corridor length constraints, floor surface variability, and the influence of assistive devices. Considerations for cross-cultural norms and population-specific thresholds have been discussed in consensus meetings convened by World Health Organization, International Parkinson and Movement Disorder Society, Stroke Association (United Kingdom), American Academy of Neurology, and International Society of Clinical Biostatistics.
Category:Physical therapy tests